Has Jonathan Glass, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,015 in general payments to Jonathan Glass, MD across 3 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Glass, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Glass, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Glass, MD

Neurology · Atlanta, GANPI 1720196488

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,015 of the $10,015 with a category attached, or 100.0%. Biogen accounts for 85.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2020 at $5,125 and has fallen 70.7% since, to $1,500 in 2022.

$10,015in general payments, 2019–2025

Across 3 payments — averaging $3338.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biogen$9K
Regeneron$2K

$5,059,732in research payments, 2019–2025

Across 75 payments — averaging $67,463 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Biogen$4.3M
Tanabe Pharma America, Inc.$365K
Genentech, Inc.$215K
Mitsubishi Tanabe Pharma Holdings America, Inc.$158K
Biohaven Pharmaceutical Holding Company Ltd.$11K
Orion Corporation$7K
plus $6K from 1 others

What the payments were for

Consulting fees$10,015100%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biogen	2	$8,515
Regeneron	1	$1,500

How this compares

$10,015 in reported general payments places this provider in the 75th percentile of 506 neurology providers in Georgia.

See all neurology providers in Georgia →

Medicare billing

Part B allowed, 2024

$22,304

Medicare patients

100

Services billed

258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OctagamImmun Globg(Igg)/Malt/Iga Ov50	13	$189,212
NuedextaDextromethorphan Hbr/Quinidine	66	$120,963
Riluzole	243	$42,178
Baclofen	42	$1,099
Tizanidine Hcl	21	$925
Gabapentin	33	$635
Glycopyrrolate	23	$634
Mexiletine Hcl	14	$531
Clonazepam	14	$356
Sodium Chloride0.9 % Sodium Chloride	14	$132
Citalopram HbrCitalopram Hydrobromide	13	$129
Amitriptyline Hcl	14	$41
Venlafaxine Hcl ErVenlafaxine Hcl	11	$3

Paid to pharmacies, not to this prescriber.

Other neurology in Atlanta

Joash LazarusAtlanta$1.1M
Jeffrey EnglishAtlanta$749K
Frank BerensonAtlanta$527K
Julio FlaminiAtlanta$501K
Douglas StuartAtlanta$493K
Robert GilbertAtlanta$412K
Lawrence SeidenAtlanta$272K
Jacqueline RosenthalAtlanta$241K
Ben ThrowerAtlanta$203K
Jaime Hatcher MartinAtlanta$165K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →